TARKAN, Ö. Et Al. 2018. Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss. JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , vol.14, no.3 , 451-455.

TARKAN, Ö., DAĞKIRAN, M., SÜRMELİOĞLU, Ö., ÖZDEMİR, S., TUNCER, Ü., Dogrusoz, M., ... Cetik, F.(2018). Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss. JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , vol.14, no.3, 451-455.

TARKAN, ÖZGÜR Et Al. "Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss," JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , vol.14, no.3, 451-455, 2018

TARKAN, ÖZGÜR Et Al. "Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss." JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , vol.14, no.3, pp.451-455, 2018

TARKAN, Ö. Et Al. (2018) . "Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss." JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , vol.14, no.3, pp.451-455.

@article{article, author={ÖZGÜR TARKAN Et Al. }, title={Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss}, journal={JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY}, year=2018, pages={451-455} }